Hana A Mansour, David Xu, Michael N Cohen, Jordan D Deaner, Jason Hsu, Yoshihiro Yonekawa, Anton Orlin, Meera D Sivalingam, Jayanth Sridhar, Ajay E Kuriyan
{"title":"通过谷歌搜索趋势评估公众对用于治疗地理萎缩症的 Pegcetacoplan 的兴趣和关注。","authors":"Hana A Mansour, David Xu, Michael N Cohen, Jordan D Deaner, Jason Hsu, Yoshihiro Yonekawa, Anton Orlin, Meera D Sivalingam, Jayanth Sridhar, Ajay E Kuriyan","doi":"10.3928/23258160-20240409-04","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To assess global trends in interest surrounding the newly Food and Drug Administration (FDA)-approved treatment for geographic atrophy, (GA), Syfovre (pegcetacoplan), and related searches.</p><p><strong>Methods: </strong>We utilized Google Trends, in order to gauge the public interest in Syfovre from October 16, 2022, to October 8, 2023.</p><p><strong>Results: </strong>Notable spikes in relative search volumes (RSV)s for \"Syfovre\" were observed in mid-to-late February 2023, and in March and April 2023, coinciding with the drug's FDA approval and introduction to the market. Of the various side effects, retinal vasculitis garnered the most significant attention, with a sharp rise in RSV in mid-July 2023. Geographic variation was evident, with the highest RSVs for \"Syfovre\" originating from users on the East Coast.</p><p><strong>Conclusion: </strong>Google Trends proves to be a useful tool for gaining insight into public interest in pegcetacoplan as a treatment for GA. <b>[<i>Ophthalmic Surg Lasers Imaging Retina</i> 2024;55:452-460.]</b>.</p>","PeriodicalId":19679,"journal":{"name":"Ophthalmic surgery, lasers & imaging retina","volume":" ","pages":"452-460"},"PeriodicalIF":0.9000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Google Search Trends to Assess Public Interest and Concern About Pegcetacoplan for the Treatment of Geographic Atrophy.\",\"authors\":\"Hana A Mansour, David Xu, Michael N Cohen, Jordan D Deaner, Jason Hsu, Yoshihiro Yonekawa, Anton Orlin, Meera D Sivalingam, Jayanth Sridhar, Ajay E Kuriyan\",\"doi\":\"10.3928/23258160-20240409-04\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To assess global trends in interest surrounding the newly Food and Drug Administration (FDA)-approved treatment for geographic atrophy, (GA), Syfovre (pegcetacoplan), and related searches.</p><p><strong>Methods: </strong>We utilized Google Trends, in order to gauge the public interest in Syfovre from October 16, 2022, to October 8, 2023.</p><p><strong>Results: </strong>Notable spikes in relative search volumes (RSV)s for \\\"Syfovre\\\" were observed in mid-to-late February 2023, and in March and April 2023, coinciding with the drug's FDA approval and introduction to the market. Of the various side effects, retinal vasculitis garnered the most significant attention, with a sharp rise in RSV in mid-July 2023. Geographic variation was evident, with the highest RSVs for \\\"Syfovre\\\" originating from users on the East Coast.</p><p><strong>Conclusion: </strong>Google Trends proves to be a useful tool for gaining insight into public interest in pegcetacoplan as a treatment for GA. <b>[<i>Ophthalmic Surg Lasers Imaging Retina</i> 2024;55:452-460.]</b>.</p>\",\"PeriodicalId\":19679,\"journal\":{\"name\":\"Ophthalmic surgery, lasers & imaging retina\",\"volume\":\" \",\"pages\":\"452-460\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmic surgery, lasers & imaging retina\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3928/23258160-20240409-04\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/5/1 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic surgery, lasers & imaging retina","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3928/23258160-20240409-04","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/1 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
Google Search Trends to Assess Public Interest and Concern About Pegcetacoplan for the Treatment of Geographic Atrophy.
Objective: To assess global trends in interest surrounding the newly Food and Drug Administration (FDA)-approved treatment for geographic atrophy, (GA), Syfovre (pegcetacoplan), and related searches.
Methods: We utilized Google Trends, in order to gauge the public interest in Syfovre from October 16, 2022, to October 8, 2023.
Results: Notable spikes in relative search volumes (RSV)s for "Syfovre" were observed in mid-to-late February 2023, and in March and April 2023, coinciding with the drug's FDA approval and introduction to the market. Of the various side effects, retinal vasculitis garnered the most significant attention, with a sharp rise in RSV in mid-July 2023. Geographic variation was evident, with the highest RSVs for "Syfovre" originating from users on the East Coast.
Conclusion: Google Trends proves to be a useful tool for gaining insight into public interest in pegcetacoplan as a treatment for GA. [Ophthalmic Surg Lasers Imaging Retina 2024;55:452-460.].
期刊介绍：
OSLI Retina focuses exclusively on retinal diseases, surgery and pharmacotherapy. OSLI Retina will offer an expedited submission to publication effort of peer-reviewed clinical science and case report articles. The front of the journal offers practical clinical and practice management features and columns specific to retina specialists. In sum, readers will find important peer-reviewed retina articles and the latest findings in techniques and science, as well as informative business and practice management features in one journal.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
